Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helfand

Showing results (521-530 of 657) with videos related to

Pageof 66
Sort By:
Journal of Medical Virology|November 26, 1998
Nonclassic measles infections in an immune population exposed to measles during a college bus tripR F Helfand, D K Kim, H E Gary, et al.
Journal of the American Chemical Society|October 5, 2006
Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfonePius S Padayatti, Anjaneyulu Sheri, Monica A Totir, et al.
Journal of Clinical Medicine|February 13, 2026
Relative Incidence of New-Onset Substance Use Disorders Following Traumatic Brain Injury: A Global Retrospective Multicenter Analysis Using the TriNetX DatabaseZachary T Hoglund, Christopher Sollenberger, Kyle W Scott, et al.
European Urology Oncology|March 21, 2026
Monogenic and Polygenic Risk for Kidney Cancer in Two Large BiobanksJun Wei, Ashley J Mulford, Zhuqing Shi, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymesKristine M Hujer, Nashaat S Hamza, Andrea M Hujer, et al.
The Journal of Biological Chemistry|July 1, 2005
Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibitionDeley Sulton, Doritza Pagan-Rodriguez, Xiang Zhou, et al.
Nature Communications|November 9, 2013
RNA editing regulates transposon-mediated heterochromatic gene silencingYiannis A Savva, James E C Jepson, Yao-Jen Chang, et al.
Cancer Research Communications|May 12, 2026
DGAT1 Drives Racially Divergent Fibroblast Activation via ERK1/2-Dependent Tumorigenic Signaling in Prostate CancerSathyavathi ChallaSivaKanaka, Mamatha Kakarla, Renee E Vickman, et al.
Research Square|May 20, 2024
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia using Patient-Reported Outcomes: Protocol for a Prospective Observational StudyAlexander P Glaser, Abigail R Smith, Dacey Maglaque, et al.
The Prostate|July 1, 2017
Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in ChinaRong Na, Dingwei Ye, Jun Qi, et al.
Pageof 66

Showing results (521-530 of 657) with videos related to

Sort By:
Pageof 66
Journal of Medical Virology|November 26, 1998
Nonclassic measles infections in an immune population exposed to measles during a college bus tripR F Helfand, D K Kim, H E Gary, et al.
Journal of the American Chemical Society|October 5, 2006
Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfonePius S Padayatti, Anjaneyulu Sheri, Monica A Totir, et al.
Journal of Clinical Medicine|February 13, 2026
Relative Incidence of New-Onset Substance Use Disorders Following Traumatic Brain Injury: A Global Retrospective Multicenter Analysis Using the TriNetX DatabaseZachary T Hoglund, Christopher Sollenberger, Kyle W Scott, et al.
European Urology Oncology|March 21, 2026
Monogenic and Polygenic Risk for Kidney Cancer in Two Large BiobanksJun Wei, Ashley J Mulford, Zhuqing Shi, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2005
Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 beta-lactamase: defining a unique family of class C enzymesKristine M Hujer, Nashaat S Hamza, Andrea M Hujer, et al.
The Journal of Biological Chemistry|July 1, 2005
Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibitionDeley Sulton, Doritza Pagan-Rodriguez, Xiang Zhou, et al.
Nature Communications|November 9, 2013
RNA editing regulates transposon-mediated heterochromatic gene silencingYiannis A Savva, James E C Jepson, Yao-Jen Chang, et al.
Cancer Research Communications|May 12, 2026
DGAT1 Drives Racially Divergent Fibroblast Activation via ERK1/2-Dependent Tumorigenic Signaling in Prostate CancerSathyavathi ChallaSivaKanaka, Mamatha Kakarla, Renee E Vickman, et al.
Research Square|May 20, 2024
Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia using Patient-Reported Outcomes: Protocol for a Prospective Observational StudyAlexander P Glaser, Abigail R Smith, Dacey Maglaque, et al.
The Prostate|July 1, 2017
Prostate health index significantly reduced unnecessary prostate biopsies in patients with PSA 2-10 ng/mL and PSA >10 ng/mL: Results from a Multicenter Study in ChinaRong Na, Dingwei Ye, Jun Qi, et al.
Pageof 66